1. 1. Asher J.H. Jr., Harrison R.W., Morell R., Carey M.L., and Friedman T.B. 1996. Effects of Pax3 modifier genes on craniofacial morphology, pigmentation, and viability: a murine model of Waardenburg syndrome variation. Genomics 34: 285–298.
2. 2. Auerbach R. 1954. Analysis of the developmental effects of a lethal mutation in the house mouse. J. Exp. Zool. 127: 305–329.
3. 3. Baxter L.L., Hou L., Loftus S.K., and Pavan W.J. 2004. Spotlight on spotted mice: a review of white spotting mouse mutants and associated human pigmentation disorders. Pigment Cell Res. 17: 215–224.
4. 4. Bogani D., Warr N., Elms P., Davies J., Tymowska-Lalanne Z., Goldsworthy M., Cox R.D., Keays D.A., Flint J., Wilson V., Nolan P., and Arkell R. 2004. New semidominant mutations that affect mouse development. Genesis 40: 109–117.
5. 5. Epstein D.J., Vekemans M., and Gros P. 1991. Splotch (Sp2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell 67: 767–774.